Correlation between serum high-mobility group box‑1 levels and high-sensitivity C-reactive protein and troponin I in patients with coronary artery disease

Yao,Heng-Chen; Zhao,Ai-Ping; Han,Qian-Feng; Wu,Lei; Yao,Dao-Kuo; Wang,Le-Xin

doi:10.3892/etm.2013.1095

July 2013 Volume 6 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July 2013 Volume 6 Issue 1

Full Size Image

Article

Correlation between serum high-mobility group box‑1 levels and high-sensitivity C-reactive protein and troponin I in patients with coronary artery disease

Authors:
- Heng-Chen Yao
- Ai-Ping Zhao
- Qian-Feng Han
- Lei Wu
- Dao-Kuo Yao
- Le-Xin Wang
View Affiliations / Copyright

Affiliations: Department of Cardiology, Liaocheng People's Hospital of Taishan Medical University, Liaocheng, Shandong 252000, P.R. China, Department of Cardiology, Beijing Friendship Hospital of China Capital Medical University, Beijing 100007, P.R. China, School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW 2678, Australia
Pages: 121-124
|
Published online on: April 30, 2013

https://doi.org/10.3892/etm.2013.1095
Expand metrics +

Abstract

The aim of this study was to evaluate the correlation between levels of serum high-mobility group box-1 (HMGB1) and high-sensitivity C-reactive protein (hs-CRP) and cardiac troponin I in patients with coronary artery disease. The levels of serum HMGB1, hs-CRP and cardiac troponin I were measured in 98 patients with coronary artery disease and in 30 healthy subjects. The correlation between serum HMGB1 levels and hs-CRP and cardiac troponin I levels was analyzed. Serum HMGB1 levels in patients with coronary artery disease were higher compared with those in healthy volunteers (63.5±15.29 vs. 21.98±4.33 µg/l; P<0.01). Serum HMGB1 levels in patients with acute myocardial infarction were higher compared with those in patients with unstable and stable angina pectoris (77.53±6.86 vs. 63.67±8.6 and 44.39±9.01 µg/l, respectively; both P<0.01). The levels of HMGB1 were positively correlated with hs-CRP and cardiac troponin I levels (r=0.657 and 0.554, respectively; both P<0.01) in patients with coronary artery disease. In conclusion, serum HMGB1 levels were elevated in patients with coronary artery disease, particularly in those with acute myocardial infarction. The levels of HMGB1 were correlated with the levels of hs-CRP and cardiac troponin I.

View Figures

View References

1.	Libby P, Ridker PM and Hansson GK; Leducq Transatlantic Network on Atherothrombosis: Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 54:2129–2138. 2009. View Article : Google Scholar : PubMed/NCBI
2.	Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB and Gudnason V: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 350:1387–1397. 2004. View Article : Google Scholar : PubMed/NCBI
3.	Ertl G and Frantz S: Healing after myocardial infarction. Cardiovasc Res. 66:22–32. 2005. View Article : Google Scholar
4.	Limana F, Germani A, Zacheo A, et al: Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit⁺ cell proliferation and differentiation. Circ Res. 97:e73–e83. 2005. View Article : Google Scholar : PubMed/NCBI
5.	Andrassy M, Volz HC, Igwe JC, et al: High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation. 117:3216–3226. 2008. View Article : Google Scholar : PubMed/NCBI
6.	Hashimoto T, Ishii J, Kitagawa F, et al: Circulating high-mobility group box 1 and cardiovascular mortality in unstable angina and non-ST-segment elevation myocardial infarction. Atherosclerosis. 221:490–495. 2012. View Article : Google Scholar : PubMed/NCBI
7.	Sørensen MV, Pedersen S, Møgelvang R, Skov-Jensen J and Flyvbjerg A: Plasma high-mobility group box 1 levels predict mortality after ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 4:281–286. 2011.PubMed/NCBI
8.	Kohno T, Anzai T, Naito K, et al: Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc Res. 81:565–573. 2009. View Article : Google Scholar : PubMed/NCBI
9.	Kitahara T, Takeishi Y, Harada M, et al: High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res. 80:40–46. 2008. View Article : Google Scholar : PubMed/NCBI
10.	Alpert JS, Thygesen K, Jaffe A and White HD: The universal definition of myocardial infarction: a consensus document: ischaemic heart disease. Heart. 94:1335–1341. 2008. View Article : Google Scholar : PubMed/NCBI
11.	Hamm CW, Bassand JP, Agewall S, et al: ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 32:2999–3054. 2011.
12.	Steg PG, James SK, Atar D, et al: ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 33:2569–2619. 2012. View Article : Google Scholar
13.	Fraker TD Jr, Fihn SD, Gibbons RJ, et al: 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. Circulation. 116:2762–2772. 2007.
14.	Ma ZS, Ma SJ, Dong MF and Wang JT: 553–557. 2009.
15.	Schiller NB, Shah PM, Crawford M, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 2:358–367. 1989. View Article : Google Scholar
16.	Yamada S, Yakabe K, Ishii J, Imaizumi H and Maruyama I: New high mobility group box 1 assay system. Clin Chim Acta. 372:173–178. 2006. View Article : Google Scholar : PubMed/NCBI
17.	Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 352:1685–1695. 2005. View Article : Google Scholar : PubMed/NCBI
18.	Gauley J and Pisetsky DS: The translocation of HMGB1 during cell activation and cell death. Autoimmunity. 42:299–301. 2009. View Article : Google Scholar : PubMed/NCBI
19.	Tian J, Avalos AM, Mao SY, et al: Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 8:487–496. 2007. View Article : Google Scholar : PubMed/NCBI